Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery

Open access
Oduro-Donkor, Dominic, Turner, Mark C., Farnaud, Sebastien, Renshaw, Derek, Kyrou, Ioannis, Hanson, Petra, Hattersley, John, Weickert, Martin O., Menon, Vinod, Randeva, Harpal S, Barber, Thomas M. · 2020 · Expert Review of Endocrinology & Metabolism

Abstract

INTRODUCTION: Bariatric surgery (primarily Laparoscopic Sleeve Gastrectomy [LSG] and Roux-en-Y Gastric Bypass [RYGB]) is an efficacious and durable therapeutic option for weight loss in obesity. The mechanisms that mediate weight loss following bariatric surgery remain incompletely understood. AREAS COVERED: Pubmed search of published data on fecal microbiota, metabolic health, LSG, and RYGB. The fecal microbiome plays a key role in the establishment and maintenance of metabolic wellbeing, and may also contribute (through fecal dysbiosis) to metabolic dysfunction. LSG and RYGB both result in characteristic, procedure-specific changes to the fecal microbiota that may mediate at least some of the resultant weight-loss and metabolically beneficial effects, when applied to the management of obesity. EXPERT OPINION: The human fecal microbiome, containing around 100 trillion microbes, evolved over millions of years and interacts symbiotically with its human host. Rodent-based studies have provided insights into the complexities of the gut-microbiome-brain axis. This includes the important role of the gut microbiome in the mediation of normal immunological development, inflammatory pathways, metabolic functioning, hypothalamic appetite regulation, and the absorption of essential nutrients as by-products of bacterial metabolism. Fecal transformation is likely to provide an important therapeutic target for future prevention and management of obesity and metabolic dysfunction.

Overview

Integrity signals

Registry

Crossref · 10.1080/17446651.2020.1801412

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 80 references

Research works printed but not linked: 2

  1. 10.1111/j.1574-6941.2002.tb00904.x · doi:10.1111/j.1574-6941.2002.tb00904.x · Paper page
  2. Remely M, 2016, End Met Imm Dis Drug Tar, 16, 99

Cited by

See all 33

Metadata

Authors
Oduro-Donkor, D., Turner, M. C., Farnaud, S., Renshaw, D., Kyrou, I., Hanson, P., Hattersley, J., Weickert, M. O., Menon, V., Randeva, H. S., & Barber, T. M.
Affiliations
  • Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK
  • Coventry University (GB)
  • Centre for Sport, Exercise and Life Sciences, Faculty of Health & Life Sciences, Coventry University, Coventry, UK
  • Aston University (GB)
  • University Hospital Coventry (GB)
Corresponding author
Barber, Thomas M.
Venue
Expert Review of Endocrinology & Metabolism
Published
2020-08-25
Volume
15
Issue
5
Pages
363-373
ISSN
  • 1744-6651 (ISSN-L)
  • 1744-8417
OpenAlex
W3044967921
Cited by
33
References
80
Citations by year
2025: 5 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 3 · 2020: 2
FWCI
1.19
Type
journal article
Language
en
Licence
other-oa
Locations
  • Expert Review of Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
  • Pure (Coventry University) (submittedVersion, other-oa)
Funders
National Institute for Health and Care Research (ACF-2019-08-003)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
fecal microbiota, bariatric surgery, laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, obesity, weight loss, metabolic dysfunction, dysbiosis, gut-brain axis, appetite regulation, gut microbiota
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Feces, Humans, Obesity, Weight Loss, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery. https://app.cochat.ai/papers/10.1080/17446651.2020.1801412
The paper
Oduro-Donkor, D., Turner, M. C., Farnaud, S., Renshaw, D., Kyrou, I., Hanson, P., Hattersley, J., Weickert, M. O., Menon, V., Randeva, H. S., & Barber, T. M. (2020). Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery. Expert Review of Endocrinology & Metabolism. https://doi.org/10.1080/17446651.2020.1801412

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.